相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial
Satoshi Suzuki et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)
The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling
Xuewu Sun et al.
REDOX BIOLOGY (2020)
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
Mohannad Ashtar et al.
CANCERS (2020)
Effect of febuxostat on oxidative stress in hemodialysis patients with endothelial dysfunction: a randomized, placebo-controlled, double-blinded study
Mona Alshahawey et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2019)
Impact of ROS Generated by Chemical, Physical, and Plasma Techniques on Cancer Attenuation
Sarmistha Mitra et al.
CANCERS (2019)
Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling
Ying Wang et al.
JOURNAL OF CELL BIOLOGY (2018)
N-acetylcysteine inhibits kinase phosphorylation during 3T3-L1 adipocyte differentiation
Daniela Soto et al.
REDOX REPORT (2017)
The two faces of reactive oxygen species (ROS) in adipocyte function and dysfunction
Jose Pedro Castro et al.
BIOLOGICAL CHEMISTRY (2016)
Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects
Maria Giulia Battelli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
N-acetylcysteine inhibits lipid accumulation in mouse embryonic adipocytes
A. Pieralisi et al.
REDOX BIOLOGY (2016)
p62 links autophagy and Nrf2 signaling
Tao Jiang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Molecular basis of the Keap1-Nrf2 system
Takafumi Suzuki et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
Brandon L. Probst et al.
PLOS ONE (2015)
Regulation of Nrf2-an update
Suryakant K. Niture et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome
Mihoko Takai et al.
ONCOLOGY LETTERS (2014)
Sestrins Activate Nrf2 by Promoting p62-Dependent Autophagic Degradation of Keap1 and Prevent Oxidative Liver Damage
Soo Han Bae et al.
CELL METABOLISM (2013)
Febuxostat, an Inhibitor of Xanthine Oxidase, Suppresses Lipopolysaccharide-Induced MCP-1 Production via MAPK Phosphatase-1-Mediated Inactivation of JNK
Johji Nomura et al.
PLOS ONE (2013)
Obesity, a health burden of a global nature
Zhi-yun Zhang et al.
ACTA PHARMACOLOGICA SINICA (2012)
Keap1 degradation by autophagy for the maintenance of redox homeostasis
Keiko Taguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
N-Acetylcysteine Reduces Markers of Differentiation in 3T3-L1 Adipocytes
Pablo Calzadilla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Inflammation, Oxidative Stress, and Obesity
Alba Fernandez-Sanchez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Reactive Oxygen Species Facilitate Adipocyte Differentiation by Accelerating Mitotic Clonal Expansion
Haemi Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Xanthine oxidoreductase is a regulator of adipogenesis and PPARγ activity
Kevin J. Cheung et al.
CELL METABOLISM (2007)
Oxidative and electophilic stresses activate Nrf2 through inhibition of ubiquitination activity if Keap1
A Kobayashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Is visceral obesity the cause of the metabolic syndrome?
JP Despres
ANNALS OF MEDICINE (2006)
Abdominal obesity, muscle composition, and insulin resistance in premenopausal women
R Ross et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Molecular mechanism of vascular disease in metabolic syndrome X
Y Matsuzawa et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Cardiovascular morbidity and mortality associated with the metabolic syndrome
B Isomaa et al.
DIABETES CARE (2001)
The perils of portliness - Causes and consequences of visceral adiposity
CT Montagne et al.
DIABETES (2000)
分享论文
